index - Myasthenia Gravis: étiologie, physiopathologie & approches thérapeutiques

Dernières publications

Chiffres clés

58 Publications avec texte intégral

Open Access

47 %

Mots clés

Myasthenia Gravis Centres germinatifs ectopiques Autoimmune disease Gender BAFF Chronic inflammation Ectopic germinal centers Gd T cells Cell-cell communication B cells Immunotherapy Complete Freund's adjuvant Immune regulation Experimental autoimmune myasthenia gravis EAMG Interferon-β MND Adaptive immunity Fragile X syndromes Long-term follow-up CCL21 Disease susceptibility COVID-19 Autoimmune diseases Interféron de type I Ferrites Cardiomyopathy Interferon IFN Etiology Anticorps monoclonal Cytokines Innate immunity Genetics Acetylcholine receptors AChR antibodies Interferon de type I Chemokines Heart failure Myasthenia gravis CD31 Genetic associations Thymectomy Experimental models CXCL13-CXCR5 Experimental autoimmune myasthenia gravis Interferon type I Human myoblasts Antimir-150 Aldehyde dehydrogenase biological marker CD31 antigen CD34 antigen CD45 antigen CD56 antigen adipocyte animal experiment animal model animal tissue antigen expression article cell differentiation cell function cell isolation cell labeling cell population cell selection controlled study endomysium enrichment culture enzyme activity enzyme substrate flow cytometry human human cell human tissue immunofluorescence in vitro study in vivo study mouse muscle biopsy muscle contraction muscle injury nonhuman phenotype skeletal muscle stem cell transplantation Adipogenesis Aldehyde Dehydrogenase Cell Differentiation Cells Cultured Flow Cytometry Humans Immunohistochemistry Muscle Cells Muscle Development Muscle Skeletal Phenotype DICER Interferon type-I Endogenous nucleic acids Interleukine-23 Acides nucléiques endogènes Interferonopathy Autoimmunity Germinal centers Interleukin 23 Quality of life CTCF FMR1 Myoblasts Immunology and Microbiology Section Exercise Age PBMC Myasthénie grave Acetylcholine receptor Experimental mouse models Germinal center Transcriptome LMNA Acetylcholine receptor antibodies COX2 Myasthenia Gravis MG Thymic epithelial cells Early-onset myasthenia gravis Th17 cells Follicular hyperplasia M3243AG Thymoma Clinical cell transplantation Interferon Animal models Glucocorticoids Lamin A/C nuclei Chronicity Inflammation Autoimmunity Inflammation Neuromuscular junction Germinal centers Th17 Muscle regeneration Inflammatory cytokines Auto-immunité Cellules th17 Conduction disease Immunity Il-23 Thymus Assay comparison Chemokine MG patients Neuromuscular junction Immune response